MORGAN STANLEY - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 41 filers reported holding APREA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$91,309
-54.8%
275,860
-11.6%
0.00%
Q3 2022$202,000
-23.5%
312,016
-11.3%
0.00%
Q2 2022$264,000
-42.5%
351,836
+42.5%
0.00%
Q1 2022$459,000
-51.0%
246,944
-24.3%
0.00%
Q4 2021$936,000
-1.0%
326,210
+76.4%
0.00%
Q3 2021$945,000
-81.0%
184,964
-81.9%
0.00%
-100.0%
Q2 2021$4,975,000
-2.3%
1,019,776
+2.2%
0.00%0.0%
Q1 2021$5,090,000
+118.7%
998,127
+111.0%
0.00%
Q4 2020$2,327,000
+42.8%
473,021
+597.9%
0.00%
Q3 2020$1,630,000
-40.5%
67,774
-4.1%
0.00%
-100.0%
Q2 2020$2,740,000
+16017.6%
70,660
+14032.0%
0.00%
Q1 2020$17,000
-97.2%
500
-96.3%
0.00%
Q4 2019$615,00013,3980.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders